For this reason, we did an inverse probability of censoring weighting sensitivity analysis, which yielded point estimates that were very similar to those of the primary analysis
Galvano, F., Li, Volti G., Malaguarnera, M., Avitabile, T., Antic, T., Vacante, M., and Malaguarnera, M
BMI over 30, or over 27 with metabolic risk factors History of weight loss followed by regain Concerns about muscle loss during weight reduction Signs of age-related growth hormone decline Commitment to dietary and exercise optimization alongside peptide use Understanding of research compound status and associated considerations Those specifically concerned about muscle preservation during weight loss make particularly appropriate candidates for the combined protocol
Because of this, its side effects are generally more pronounced and prolonged compared to standard IGF-1
Similarly, the oral GLP-1 RA will also need to demonstrate their cardiovascular safety in these populations (NCT05803421)